GynecologyGynecology2079-56962079-5831Consilium Medicum28628Review ArticleCurrent state of the problem of habitual loss of pregnancy: discussion questions of causes and risk factors, tactics of periconceptive managementSkvortsovaM Yumargodus@mail.ruPrilutskaiaS G-Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation15042017192596509042020Copyright © 2017, Consilium Medicum2017The literary review presents modern views on the problem of habitual loss of pregnancy. Questions of terminology, causes and risk factors, strategic directions of pre-survey examination and per-conceptual management of patients with this pathology are discussed. The causes of habitual loss of pregnancy are extremely diverse and, as a rule, are interrelated. These are genetic causes (chromosomal abnormalities of the embryo or one or both parents), endocrine disorders (the endpoint of which is a violation of the functional and structural state of the endometrium), immunological factors (realized at the level of local disruption of the production of various cytokines, normally providing implantation and placentation processes) and hemotaziologic disorders (the most studied of which is AFS). An important role of pre-gestational detection and correction of risk factors for pregnancy loss in a married couple is shown.spontaneous abortionhabitual loss of pregnancypregravid preparationсамопроизвольное прерывание беременностипривычная потеря беременностипрегравидарная подготовка[Акушерство: национальное руководство. Под ред. Э.К.Айламазяна, В.И.Кулакова, В.Е.Радзинского, Г.М.Савельевой. М.: ГЭОТАР-Медиа, 2014.][Royal College of Obstetricians and Gynaecologists. The Investigation and Treatment of Couples with Recurrent First - trimester and Second - trimester Miscarriage. Green - top Guideline №17. 2011. Apr. Available from: http://www.rcog.org.uk/globalassets/ documents/ guidelines/gtg_17.pdf][WHO Library Cataloguing in Publication. Good clinical diagnostic practice: a guide for clinicians in developing countries to the clinical diagnosis of disease and to making proper use of clinical diagnostic services. By Jane Carter et al. WHO Regional Publications, Eastern Mediterranean Series, 27).][Management of pregnancy, childbirth and the postpartum period in the presence of female genital mutilation Department of Gender, Women and Health Department of Reproductive Health and Research Family and Community Health World Health Organization 2001 from: htpp://www.who.intentitygenderother_healthmanageofpregnan.pdf][Practice Committee of American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertil Steril 2013; 99 (1): 63. PMID: 23095139.][Сидельникова В.М., Сухих Г.Т. Невынашивание беременности. Руководство для практикующих врачей. М.: МИА; 2010.][Клинические рекомендации (протокол лечения). Выкидыш в ранние сроки беременности: диагностика и тактика ведения, 2016 год. htpp://mz.mosreg.ru/upload/iblock /vykydish-v-rannie-sroki-beremennosti-diagnostika-i-taktika-vedenya.pdf][Прегравидарная подготовка: клинический протокол. Авт. - разраб. В.Е.Радзинский и др. М.: StatusPraesens, 2016. (Утвержден Протоколом №4П-16 Президиума Правления Междисциплинарной ассоциации специалистов репродуктивной медицины - МАРС от 28.06.2016, Москва). https://praesens.ru/pregravidarnaya-podgotovka-klinicheskiy-protokol-mezhdistsiplinarnoy-assotsiatsi..][National Institute for Health and Clinical Excellence. Ectopic pregnancy and miscarriage: diagnosis and initial management in early pregnancy of ectopic pregnancy and miscarriage. NICE Clinical Guideline 154. Manchester (UK): NICE, 2012. htpp://www.nice.org.uk/ guidance/cg154/resources/guidance-ectopis-pregnancy-and-miscarriage-pdf][Савельева Г.М., Шалина Р.И., Сичинава Л.Г. и др. Акушерство. Учебник для вузов. М., 2009.][Stephenson M.D, Awartani K.A, Robinson W.P. Cytogenetic analysis of miscarriages from couples with recurrent miscagiage: a case - control study. Hum Reprod 2002; 17 (2): 446-51.][Tunç E, Demirhan O, Demir C, Tastemir D. Cytogenetic study of recurrent miscarriages and their parents. Genetika 2007; 43 (4): 545-52. PMID: 17555132.][Suzumori N, Sugiura-Ogasawara M. Genetic factors as a cause of miscarriage. Curr Med Chem 2010; 17 (29): 3431-7. PMID: 20712563.][Kedar P, Warang P, Ghosh K. Recessive congenital mrthemoglobinemia due to NADH-cytochrome b5 reductase deficiency associated with recurrent early pregnancy loss (REPL) in an Indian family. Ann Hematol 2012; 91: 1985-6.][Argov Z, de Visser M. What we do know about pregnancy in hereditary neuromuscular disorders. Neuromuscul Disord 2009; 19: 675-9.][Carvalho B, Dória S, Ramalhob C et al. Aneuploidies detection inmiscarriages and fetal deaths using multiplex ligation - depentent probeamplification: an alternative for speeding up results? Eur J Obstet Gynecol Reprod Biol 2010; 153: 151-5.][Kwinecka-Dmitriew B, Zakrzewska M, Latos-Bieleńska A et al. Częst ość wystę powania aberracji chromosomowych w materiale z poronień. Ginekol Pol 2010; 81: 896-901.][Berghella V. Early pregnancy loss: in book Obstetric Evidence Based Guidelines. 2nd ed. 2012; p. 142-9.][Reid S.M, Middleton P, Cossich M.C et al. Interventions for clinical and subclinical hypothyroidism pre - pregnancy and during pregnancy. Cochrane Database of Systematic Reviews 2013. Issue 5. Art. No.: CD007752. DOI: 10.1002/14651858.CD007752.pub3.][Эндокринология. Российские клинические рекомендации. Под ред. И.И.Дедова, Г.А.Мельниченко. М.: ГЭОТАР-Медиа, 2016.][Benhadi N, Wiersinga W.M, Reitsma J.B et al. Higher maternal TSH levels in pregnancy are associated with increased risk for miscarriage, fetal or neonatal death. Eur J Endocrinol 2009; 160: 985-91. PMID: 19273570.][Hengxi Chen, Jing Fu, Wei Huang. Dopamine agonists for preventing future miscarriage in women with idiopathic hyperprolactinemia and recurrent miscarriage history. Cochrane Pregnancy and Childbirth Group from: http:// onlinelibrary.wiley.com/ doi/10.1002/14651858. CD008883.pub2/full. DOI: 10.1002/14651858.CD008883.pub2.][Melmed F et al. Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline JCEM, 2013. PMID: 21296991.][Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Клинические рекомендации. 7-й вып. Под ред. И.И.Дедова, М.В.Шестаковой. Сахарный диабет. 2015; 18 (1S): 1-112.][Melamed N, Hod M. Perinatal mortality in pregestationaldiabetes. Int J Gynaecol Obstet 2009; 104: 20-4. PMID: 19155005.][Gutaj P, Zawiejska A, Wender-Ożegowska E et al. Maternal factors predictive of first trimester pregnancy loss in women with pregestational diabetes. Pol Arch Med Wewn 2013; 123: 21-8. PMID: 23302725.][Furber C.M, Mc Gowan L, Bower P et al. Antenatal interventions for reducing weight in obese women for improving pregnancy outcome. Cochrane Database of Systematic Reviews 2013. Issue 1. CD009334. DOI: 10.1002/14651858.CD009334.pub2.][Opray N, Grivell R.M, Deussen A.R, Dodd J.M. Directed preconception health programs and interventions for improving pregnancy outcomes for women who are overweight or obese. Cochrane Database of Systematic Reviews 2015. Issue 7. CD010932. DOI: 10.1002/14651858.CD010932.pub2.][Franik S, Kremer J.A.M, Nelen W.L.D.M, Farquhar C. Aromatase inhibitors for subfertile women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews 2014. Issue 2. CD010287. DOI: 10.1002/14651858.CD010287.pub2.][Sinawat S, Buppasiri P, Lumbiganon P, Pattanittum P. Long versus short course treatment withmetformin and clomiphene citrate for ovulation induction in women with PCOS. Cochrane Database of Systematic Reviews 2012. Issue 10. CD006226. DOI: 10.1002/14651858.CD006226.pub3.][Van der Linden M, Buckingham K, Farquhar C et al. Luteal phase support for assisted reproduction cycles. Cochrane Database of Systematic Reviews 2015. Issue 7. CD009154. DOI: 10.1002/14651858.CD009154.pub3.][The Practice Committee of the American Society for Reproductive Medicine Evaluation and Treatment of Recurrent Pregnancy Loss A Committee Opinion. Fertil Steril 2012; 98: 1103-11. Issue 5.][Carp H. A systematic review of dydrogesterone for the treatment of recurrence miscarriage. http://informahealthcare.com/gye. DOI: 10.3109/09513590.2015.1006618.][Investigation and treatment of couples with recurrent miscarriage - clinical guideline. Royal Cornwall hospitals. http://www.rcht.nhs.uk/Documents Library/RoyalCornwall HospitalsTrust /Clinical/Gynaecology/InvestigationAndTreatmentOfCouplesWithRecurrentMiscarraigeJune 2014.pdf][Alijotas-Reig J, Garrido-Gimenez C. Current concepts and new trends in the diagnosis and management of recurrent miscarriage. Obstet Gynecol Surv 2013; 68 (6): 445-66. https://www.ncbi.nlm.nih.gov/pubmed/23942472][Miyakis S, Lockshin M.D, Atsumi T et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4 (2): 295-306. PMID: 16420554.][Empson M.B, Lassere M, Craig J.C, Scott J.R. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Pregnancy and Childbirth Group. DOI: 10.1002/14651858.CD002859.pub2.][Ziakas P.D, Pavlou M, Voulgarelis M. Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: A systematic review and meta - analysis. Obstet Gynecol 2010; 115: 1256-62. PMID: 20502298.][De Jong P.G, Kaandorp S, di Nisio M et al. Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia. Cochrane Database of Systematic Reviews 2014. Issue 7. CD004734. DOI: 10.1002/14651858.CD004734.pub4.][ACOG, WHCP, ACOG Practice Bulletin №138: Inherited thrombophilias in pregnancy. Obstet Gynecol 2013; 122 (3): 706-17. PMID: 23963422.][Virkus R.A, Lökkegaard E, Lidegaard Ŏ et al. Risk Factors for Venous Thromboembolism in 1,3 Million Pregnancies: A Nationwide Prospective Cohort. PLoS ONE 2014; 9 (5): e96495. PMID: 24788753.][Макацария А.Д., Белобородова Е.В., Баймурадова С.Н., Бицадзе В.О. Гипергомоцистеинемия и осложнения беременности. М.: Триада-Х, 2005.][Беспалова О.В. Генетические факторы риска невынашивания беременности. Автореф. дис … д - ра мед. наук. СПб., 2009.][Mujawar S.A, Patil V.W, Daver R.G. Study of serum homocysteine, folic acid and vitamin B12 in patients with preeclampsia. Indian J Clin Biochem 2011; 26 (3): 257-60.][Rodriguez-Guillen M.R, Torres-Sanchez L, Chen J et al. Dietary consumption of B vitamins, maternalMTHFR polymorphisms and risk for spontaneous abortion. Salud Publica Mex 2009; 51 (1): 19-25.][De-Regil L.M, Fernández-Gaxiola A.C, Dowswell T, Peña-Rosas J.P. Effects and safety of periconceptional folate supplementation for preventing birthdefects. Cochrane Database Syst Rev 2010; 10: CD007950.][Imbard A, Benoist J-F, Blom H.J. Neural Tube Defects, Folic Acid and Methylation. Int J Environ Res Public Health 2013; 10 (9): 4352-89.][Mosley B.S, Cleves M.A, Siega-Riz A.M et al. Neural tube defects and maternalfolate intake among pregnancies conceived after folic acid fortificationin the United States. Am J Epidemiol 2009; 169: 9-17.][Oyama K. Folic acid prevents congenital malformations in the offspringdiabetic mice. Endocr J 2009; 56 (1): 29-37.][Zhang T, Xin R, Gu X, Wang F. Maternal serum vitamin B12, folate and homocysteine and the risk of neural tube defects in the offspring in a highеriskarea of China. Public Health Nutr 2009; 12 (5): 680-6.][Макаров О.В., Козлов П.В., Насырова Д.В. Синдром задержки развития плода: современные подходы к фармакотерапии. Рос. вестн. акушера - гинеколога. 2003; 3 (6): 18-22.][Озолиня Л.А., Кажечева А.З. Прегравидарная подготовка женщин с гипергомоцистеинемией // Гинекология. 2013; 15 (2): 100-3.][Klemmensen A, Tabor A, Osterdal M.L. Intake of vitamin C and E in pregnancyand risk of pre - eclampsia: prospective study among 57346 women. BJOG 2009; 116 (7): 964-74.][Прилепская В.Н., Кутуева Ф.Р., Кулешов В.М. и др. Результаты Российской неинтервенционной (наблюдательной) программы по назначению витаминно - минерального комплекса для профилактики гиповитаминозов и дефицита минеральных веществ ПРОГНОСТИК у беременных женщин. Гинекология. 2016; 18 (4): 5-12.][Прилепская В.Н., Короткова Н.А. Применение витаминно - минеральных комплексов при подготовке к зачатию, во время беременности и после родов. Эффективная фармакотерапия. 2013; 51: 24-8.][Доброхотова Ю.Э., Джобава Э.М., Степанян А.В. Рациональная витаминотерапия в группах риска по развитию акушерских осложнений // Гинекология. 2011; 13 (1): 50-3.][Громова О.А., Торшин И.Ю., Серов В.Н. и др. Хром, селен, молибден: значимость в нутрициальной поддержке беременности // Гинекология. 2015; 17 (5).][Mori M, Bogdan A, Balassa T et al. The deciduas - the maternal bed embracing the embryo - maintains the pregnancy. Semin Immunopathol 2016; 38: 635-49. DOI 10.1007/s00281-016-0574-0.][Wong L.F, Porter T.F, Scott J.R. Immunotherapy for recurrent miscarriage. Cochrane Database of Systematic Reviews 2014. Issue 10. CD000112. DOI: 10.1002/ 14651858.CD000112. pub3.][Овчинников Р.И., Гамидов С.И., Попова А.Ю. и др. Привычное невынашивание беременности - что зависит от мужчины? Акуш. и гинекол. 2016; 12: 15-23.][Буштырева И.О. Открытое рандомизированное сравнительное исследование эффективности, переносимости и безопасности препарата Витрум Пренатал Форте у пациенток с угрозой преждевременных родов на сроке 28-32 недели беременности. ФУВ РГМУ.][Дашкевич В.Е., Давыдова Ю.В. Применение Витрум Пренатал Форте у беременных группы высокого перинатального риска. Институт педиатрии, акушерства и гинекологии АМН Украины.][Курбанов Д.Д. Отчет о Клиническом исследовании Витрум Пренатал Форте у беременных женщин с преэклампсией. 2007.][Кузьмин В.Н. Открытое сравнительное клиническое исследование эффективности, безопасности применения ВПФ у беременных женщин с цитомегаловирусной инфекцией. Центр перинатальных инфекций МГМСУ, 2007-2008.]